NPA Seeks Clarified FDA Guidance On OTC Sunscreen Ingredient Review
This article was originally published in The Rose Sheet
Executive Summary
In response to FDA draft guidances mandated by the Sunscreen Innovation Act, the Natural Products Association pushes for clarification on GRASE data-submission requirements for combination active ingredients and urges the agency to make use of its Nonprescription Drug Advisory Committee beyond what the law requires to ensure that sunscreen ingredients receive attention and sponsors can stay compliant with SIA timetables.